Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vulvar and Vaginal Atrophy”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Large-scale testing (Phase 3)Study completedNCT01358760
What this trial is testing

Dehydroepiandrosterone (DHEA) Against Vaginal Atrophy

Who this might be right for
Vaginal Atrophy
EndoCeutics Inc. 450
Testing effectiveness (Phase 2)WithdrawnNCT04159493
What this trial is testing

Controlled Phase 2 Study to Determine Lowest Efficacious Dose of Ovestin in Vulvar and Vaginal Atrophy

Who this might be right for
Vaginal Atrophy
Aspen USA Inc
Not applicableActive Not RecruitingNCT04081805
What this trial is testing

LASER and Radiofrequency for Treatment of Vaginal Vulvar Atrophy (VVA) in Women Treated for Breast Cancer (EPMLARF-arm2)

Who this might be right for
Vaginal AtrophyVulva; AtrophyBreast Cancer
Federal University of São Paulo 195
Large-scale testing (Phase 3)UnknownNCT03782480
What this trial is testing

Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy

Who this might be right for
MenopauseGenitourinary Syndrome of MenopauseVulvovaginal Atrophy+2 more
Center for Vulvovaginal Disorders 40
Large-scale testing (Phase 3)Study completedNCT02668796
What this trial is testing

To Study Generic Estradiol 10 mcg Vaginal Tablets in the Treatment of Vulvar and Vaginal Atrophy in Post Menopausal Women.

Who this might be right for
Vulvar and Vaginal Atrophy
Glenmark Pharmaceuticals Ltd. India 522
Large-scale testing (Phase 3)Study completedNCT02770365
What this trial is testing

Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal Atrophy

Who this might be right for
Atrophy
Padagis LLC 695
Large-scale testing (Phase 3)Study completedNCT01779947
What this trial is testing

Study to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 mcg and Vagifem® 10 mcg and Compare to Placebo

Who this might be right for
Atrophic Vaginitis Due to Menopause
Amneal Pharmaceuticals, LLC 519
Post-approval studies (Phase 4)Study completedNCT04705883
What this trial is testing

Vaginal Prasterone In Vaginal Atrophy In Breast Cancer Survivors

Who this might be right for
Vulvar AtrophyBreast CancerGenitourinary Syndrome of Menopause
Hospital Clinic of Barcelona 10
Testing effectiveness (Phase 2)Study completedNCT02449902
What this trial is testing

TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy

Who this might be right for
MenopauseVulvovaginal AtrophyPainful Intercourse+1 more
TherapeuticsMD 50
Large-scale testing (Phase 3)Study completedNCT01256684
What this trial is testing

DHEA Against Vaginal Atrophy - 3-Month Efficacy Study

Who this might be right for
Vaginal Atrophy
EndoCeutics Inc. 255
Large-scale testing (Phase 3)Study completedNCT00276094
What this trial is testing

A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women

Who this might be right for
AtrophyVaginal Diseases
Shionogi 826
Large-scale testing (Phase 3)Study completedNCT03332303
What this trial is testing

Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy

Who this might be right for
Vulvar and Vaginal Atrophy
Prasco LLC 540
Large-scale testing (Phase 3)UnknownNCT06514586
What this trial is testing

The Efficacy of Topical Vaginal Oxytocin Gel in Postmenopausal Women With Vulvovaginal Atrophy

Who this might be right for
Vaginal AtrophyGenitourinary Syndrome of MenopauseVulvar Atrophy
Oxagon 244
Large-scale testing (Phase 3)Study completedNCT00727129
What this trial is testing

Study to Evaluate Divigel for the Treatment of Postmenoupausal Symptoms

Who this might be right for
Postmenopausal Symptoms
Upsher-Smith Laboratories 495
Testing effectiveness (Phase 2)Study completedNCT05378269
What this trial is testing

Study of Intravaginal Tamoxifen in PostMenopausal Women With VVA

Who this might be right for
Vulvar Atrophy
Daré Bioscience, Inc. 17
Large-scale testing (Phase 3)Study completedNCT01585558
What this trial is testing

Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus

Who this might be right for
AtrophyVaginal Diseases
Shionogi 180
Not applicableStudy completedNCT03063684
What this trial is testing

Fractional / Pixel CO2 Laser Treatment of Vulvar Atrophy and Lichen Sclerosus

Who this might be right for
Vaginal AtrophyLichen Sclerosus
Hadassah Medical Organization 16
Post-approval studies (Phase 4)Study completedNCT00160173
What this trial is testing

Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal Atrophy

Who this might be right for
Postmenopausal Symptoms
ASCEND Therapeutics 221
Large-scale testing (Phase 3)Study completedNCT01586364
What this trial is testing

Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus

Who this might be right for
AtrophyVaginal Diseases
Shionogi 301
Large-scale testing (Phase 3)Study completedNCT00566982
What this trial is testing

A Clinical Study to Evaluate the Safety of Ospemifene

Who this might be right for
AtrophyVaginal Diseases
Shionogi 426
Next Page